256 related articles for article (PubMed ID: 28780601)
1. Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms.
Taniguchi Y; Tanaka H; Luis EJ; Sakai K; Kumode T; Sano K; Serizawa K; Rai S; Morita Y; Hanamoto H; Tsubaki K; Nishio K; Matsumura I
Int J Hematol; 2017 Nov; 106(5):691-703. PubMed ID: 28780601
[TBL] [Abstract][Full Text] [Related]
2. High Level of Circulating Microparticles in Patients with BCR/ABL Negative Myeloproliferative Neoplasm - a Pilot Study.
Aswad MH; Kissová J; Rihova L; Zavrelova J; Ovesná P; Penka M
Klin Onkol; 2019; 32(2):109-116. PubMed ID: 30995850
[TBL] [Abstract][Full Text] [Related]
3. Increasing procoagulant activity of circulating microparticles in patients with Philadelphia-negative myeloproliferative neoplasms: a single-centre experience.
Kissova J; Ovesna P; Bulikova A; Zavřelova J; Penka M
Blood Coagul Fibrinolysis; 2015 Jun; 26(4):448-53. PubMed ID: 25828967
[TBL] [Abstract][Full Text] [Related]
4. Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms.
Duchemin J; Ugo V; Ianotto JC; Lecucq L; Mercier B; Abgrall JF
Thromb Res; 2010 Sep; 126(3):238-42. PubMed ID: 20656333
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of the relevance of thrombin generation and procoagulant activity in thrombotic risk assessment in BCR-ABL-negative myeloproliferative neoplasm patients.
Baccouche H; Ben Jemaa M; Chakroun A; Chadi S; Mahjoub S; Sfar I; Gorgi Y; Ben Romdhane N
Int J Lab Hematol; 2017 Oct; 39(5):502-507. PubMed ID: 28497580
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Significance of Circulating Microparticles Concerning Thrombosis in BCR/ABL1-negative Myeloproliferative Neoplasms.
Aswad MH; Kissova J; Ovesna P; Rihova L; Penka M
In Vivo; 2021; 35(6):3345-3353. PubMed ID: 34697168
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil extracellular trap formation and circulating nucleosomes in patients with chronic myeloproliferative neoplasms.
Marin Oyarzún CP; Carestia A; Lev PR; Glembotsky AC; Castro Ríos MA; Moiraghi B; Molinas FC; Marta RF; Schattner M; Heller PG
Sci Rep; 2016 Dec; 6():38738. PubMed ID: 27958278
[TBL] [Abstract][Full Text] [Related]
8. Administration of direct oral anticoagulants in patients with myeloproliferative neoplasms.
Ianotto JC; Couturier MA; Galinat H; Mottier D; Berthou C; Guillerm G; Lippert E; Delluc A
Int J Hematol; 2017 Oct; 106(4):517-521. PubMed ID: 28623609
[TBL] [Abstract][Full Text] [Related]
9. Microparticles from splenectomized β-thalassemia/HbE patients play roles on procoagulant activities with thrombotic potential.
Klaihmon P; Phongpao K; Kheansaard W; Noulsri E; Khuhapinant A; Fucharoen S; Morales NP; Svasti S; Pattanapanyasat K; Chaichompoo P
Ann Hematol; 2017 Feb; 96(2):189-198. PubMed ID: 27900452
[TBL] [Abstract][Full Text] [Related]
10. Thrombosis in myeloproliferative neoplasms.
Falanga A; Marchetti M
Semin Thromb Hemost; 2014 Apr; 40(3):348-58. PubMed ID: 24610470
[TBL] [Abstract][Full Text] [Related]
11. Changes in response to antiaggregatory treatment in patients with myeloproliferative neoplasms: a sequential study using multiple electrode aggregometry.
Robier C; Stettin M; Neubauer M
Blood Coagul Fibrinolysis; 2013 Dec; 24(8):869-73. PubMed ID: 24176950
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of circulating microparticles in Ph
Zhang W; Qi J; Zhao S; Shen W; Dai L; Han W; Huang M; Wang Z; Ruan C; Wu D; Han Y
Oncol Lett; 2017 Aug; 14(2):2531-2536. PubMed ID: 28789461
[TBL] [Abstract][Full Text] [Related]
13. Incidence and impact of atrial arrhythmias on thrombotic events in MPNs.
Mahé K; Delluc A; Chauveau A; Castellant P; Mottier D; Dalbies F; Berthou C; Guillerm G; Lippert E; Ianotto JC
Ann Hematol; 2018 Jan; 97(1):101-107. PubMed ID: 29164292
[TBL] [Abstract][Full Text] [Related]
14. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.
Uszyński M; Zekanowska E; Uszyński W; Kuczyński J; Zyliński A
Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):37-41. PubMed ID: 21664032
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic disease in the myeloproliferative neoplasms.
Falanga A; Marchetti M
Hematology Am Soc Hematol Educ Program; 2012; 2012():571-81. PubMed ID: 23233637
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease.
Kambas K; Chrysanthopoulou A; Vassilopoulos D; Apostolidou E; Skendros P; Girod A; Arelaki S; Froudarakis M; Nakopoulou L; Giatromanolaki A; Sidiropoulos P; Koffa M; Boumpas DT; Ritis K; Mitroulis I
Ann Rheum Dis; 2014 Oct; 73(10):1854-63. PubMed ID: 23873874
[TBL] [Abstract][Full Text] [Related]
17. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
Iványi JL; Marton E; Plander M
Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
[TBL] [Abstract][Full Text] [Related]
18. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
19. Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia.
Gheldof D; Haguet H; Dogné JM; Bouvy C; Graux C; George F; Sonet A; Chatelain C; Chatelain B; Mullier F
J Thromb Thrombolysis; 2017 Feb; 43(2):224-232. PubMed ID: 28074413
[TBL] [Abstract][Full Text] [Related]
20. Tissue-factor-bearing microparticles (MPs-TF) in patients with acute ischaemic stroke: the influence of stroke treatment on MPs-TF generation.
Świtońska M; Słomka A; Sinkiewicz W; Żekanowska E
Eur J Neurol; 2015 Feb; 22(2):395-401, e28-9. PubMed ID: 25370815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
